ImmunityBio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
IBRX chart
What traders are saying about $IBRX
Latest postsImmunityBio, Inc. news
- IBRX Stock Rises Overnight: Jim Cramer Backs ImmunityBio As A ‘Very Good Spec’ Amid Biotech Takeover Wave
stocktwits.com ·
- Weekly Recap: sBLA due Q4 2026 and ANKTIVA approval for papillary NMIBC
TradingView ·
- IBRX Stock Declines — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data
Stocktwits ·
- Anktiva Vs Keytruda: ImmunityBio Exec Chair Slams FDA For Double Standards In Approvals
Stocktwits ·
- The Secret Biotech Billionaire Behind ImmunityBio (IBRX) Revealed Richarlison (8U3pwejyVu)
Unisba Media ·
- H.C. Wainwright keeps USD 15.00 target for ImmunityBio stock
ad-hoc-news.de ·
- ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ
Timothy Sykes ·
- ImmunityBio, Inc. Estimates – NASDAQ:IBRX
TradingView ·
- Immunitybio Stock Price Forecast. Should You Buy IBRX?
StockInvest.us ·
- ImmunityBio, Inc. (IBRX) Options Chain - Yahoo Finance
Yahoo! Finance Canada ·
- ImmunityBio (IBRX) Could Be 39% Undervalued After Key Bladder Cancer Trial Milestone
Simply Wall Street ·
- “Cancer Treatment Without Bladder Removal”… ImmunityBio's 'ANKTIVA', Fully Covers BCG-Unresponsive Bladder Cancer, Opening 'Immunotherapy 2.0'
아이알팜 ·
ImmunityBio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $113.3M | $14.7M | $622,000 | $240,000 |
| Net income | -$351.5M | -$413.6M | -$583.9M | -$417.3M |
| Diluted EPS | $-0.38 | $-0.62 | $-1.15 | $-1.04 |
| Total assets (year end) | $501.9M | $382.9M | $504.5M | $362.4M |
| Cash and equivalents (year end) | $88.3M | $143.4M | $265.5M | $104.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About ImmunityBio, Inc.
- Ticker
- IBRX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1326110
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
Frequently asked questions
What exchange is ImmunityBio, Inc. listed on?
ImmunityBio, Inc. trades on the Nasdaq under the ticker symbol IBRX.
What industry is ImmunityBio, Inc. in?
ImmunityBio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is ImmunityBio, Inc. headquartered?
ImmunityBio, Inc.'s business address on file with the SEC is in San Diego, CA.
When does ImmunityBio, Inc.'s fiscal year end?
ImmunityBio, Inc.'s fiscal year ends on December 31.
How much revenue did ImmunityBio, Inc. report?
ImmunityBio, Inc. reported $113.3M in revenue for calendar year 2025, according to its SEC filings.